SAN DIEGO, July 15, 2026 /PRNewswire/ — QuidelOrtho Corporation (Nasdaq: QDEL)(“QuidelOrtho”), a leading global provider of diagnostic solutions, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of restricted stock units (“RSUs”) with…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
